Remove 2030 Remove Hospitals Remove Packaging
article thumbnail

A New Regulatory Approach to Drive Sustainable Medicines

ISPE

As such there’s a growing question of how the industry will improve the sustainability profile of its existing medicines and ensure that sustainability is designed into new medicines, such as products, with a reduced environmental risk, greener manufacturing technologies, and recyclable delivery systems and packaging. 9 December 2021.

article thumbnail

Philips on designing innovation and cultivating partnerships – part two

pharmaphorum

It’s a package, and sometimes we deploy one or two modules, sometimes multiple modules in a project. The primary care facility also has access to the system, as does the hospital. This venture is part of Philips’ strategy for annually improving the lives of 400 million people in communities with poor access to care by 2030.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could virtual reality become an essential tool for healthcare education?

pharmaphorum

The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. According to the World Health Organization, the world will need more than 40 million new doctors, nurses, frontline healthcare workers, and various other healthcare professionals by 2030.

Vaccines 145
article thumbnail

Polypharmacy and ageing

Hospital Pharmacy Europe

In order to reduce the number of drug-related problems, much effort has been directed at identification of potentially inappropriate medicines (PIMs) and measures to reduce prescribing of high-risk drugs, said Professor Tobias Dreischulte (Institute of Family Practice and General Medicine, LMU Hospital, Munich, Germany).

article thumbnail

Considerations for a Decentralized Manufacturing Paradigm

ISPE

4 , 5 Additionally, reducing shipping limitations—such as packaging, storage, and transportation durations—helps speed up patient access in certain instances while ensuring there is no negative impact to the product’s critical quality attributes (CQAs). These new operating models can help enable and accelerate the efforts of Pharma 4.0™

article thumbnail

Transitioning to digital product information to ensure a sustainable future

European Pharmaceutical Review

Digital innovation is a critical piece of the response to this challenge, and as part of our ongoing commitment to the environment, AstraZeneca has begun the transition to electronic product information (ePI) , with the goal of introducing ePI across all products by 2030. billion litres of water could be saved each year.